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 Tissue engineered scaffolds are a powerful means of healing craniofacial bone defects 
arising from trauma or disease. Murine models of critical-sized bone defects are especially useful 
in understanding the role of microenvironmental factors such as vascularization on bone 
regeneration. In this thesis, we review the previously employed bone graft methods used to treat 
orthopedic tissue defects, the transition of therapeutic approaches to tissue engineering based 
regimes, and the various imaging modalities which may be used to characterize osteogenesis and 
angiogenesis within defect sites. Additionally, we demonstrate the capability of a novel 
multimodality imaging platform capable of acquiring in vivo images of microvascular 
architecture, microvascular blood flow and tracer/cell tracking via intrinsic optical signaling 
(IOS), laser speckle contrast (LSC) and fluorescence (FL) imaging, respectively in a critical-
sized calvarial defect model. Defects that were 4 mm in diameter were made in the calvarial 
regions of mice followed by the implantation of osteoconductive scaffolds loaded with human 
adipose-derived stem cells (ASCs) embedded in fibrin gel. Using IOS imaging, we were able to 
visualize microvascular angiogenesis at the graft site and extracted morphological information 
such as vessel radius, length, and tortuosity two weeks after scaffold implantation. FL imaging 
allowed us to assess functional characteristics of the angiogenic vessel bed such as time-to-peak 
of a fluorescent tracer, and also allowed us to track the distribution of fluorescently tagged 
human umbilical vein endothelial cells (HUVECs). Finally, we employed LSC to characterize 
the in vivo hemodynamic response and maturity of the remodeled microvessels in the scaffold 
microenvironment. In this thesis, we provide a methodical framework for imaging tissue 
engineered scaffolds, processing the images in order to extract key microenvironmental 
parameters, and visualizing this data in a manner that enables the characterization of the vascular 
phenotype and its effect on bone regeneration. Such multimodality imaging platforms can inform 
optimization and design of tissue engineered scaffolds and elucidate the factors that promote 
enhanced vascularization and bone formation.  
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Fig. 1 In vivo imaging of the calvarial defect model. (a) Benchtop multi-contrast 
optical imaging system used to acquire in vivo images of the microenvironment 
of engineered scaffolds implanted in a calvarial defect model. (b). Diagram of 
the calvarial defect area location on a mouse skull. (c) Superior view of a 3D-
printed polycaprolactone scaffold implanted in the calvarial defect. (d) 
Magnified view of 4 mm 3D printed scaffold seeded with ASCs suspended in a 
fibrin gel. (Calvarial Diagram adapted from: Zhang W, Zhu C, Ye D, Xu L, 
Zhang X, Wu Q, et al. Porous Silk Scaffolds for Delivery of Growth Factors 
and Stem Cells to Enhance Bone Regeneration. PLoS ONE. 2014;9(7):1.) 
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Fig. 2 Fig. 2: Multi-contrast in vivo imaging of the graft microenvironment. Flow 
chart illustrating key microenvironmental factors that are interrogated in vivo 
(green) within the calvarial defect site; the in vivo optical contrast mechanism 
employed (red) to assay these factors; the imaging method employed (blue), 
and the metrics computed for characterizing the in vivo graft 
microenvironment. * Can also be used to track fluorescently labeled stem cell 
survival and location. 
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Fig. 3 Fig. 3:  Analysis of vascular morphology in the in vivo graft microenvironment. 
(a) IOS image of the calvarial defect site two weeks after implantation wherein 
the vasculature is dark due to green light absorption. PCL scaffold is outlined 
by the gray circle.  (b) LSC image of the same FoV wherein perfused blood 
vessels appear bright due to red laser light being scattered by moving 
erythrocytes. PCL scaffold is again outlined by a gray circle. (c, d) Images in 
(a, b) overlaid with their respective binary vessel masks. (e) Combination of the 
vessel masks in (c, d) to provide a holistic mask of all the vessels that are 




corresponding to the vessel segments identified in (e). (g, h, i) Distribution of 
vessel characteristics for the sample shown in (e). 
 
Fig. 4 Fig. 4:  Analysis of tracer kinetics and cell distribution in the in vivo graft 
microenvironment. (a) Representative time series of fluorescent images 
acquired after injection of the fluorescent intravascular tracer FITC-dextran. 
PCL scaffold is outlined by the large gray dashed circles.(b) Plot of the 
fluorescence intensity from the ROI (red circle) in (a) illustrating the transit of 
the intravascular tracer through the vasculature within the graft. Red points 
correspond to the time points for which snapshots are shown in (a). (c) Time-to-
peak (TTP) map computed from the tracer data for each vessel segment within 
the FoV. (d) Fluorescent image of a scaffold seeded with a mixture of ASCs 
and red fluorescent protein (RFP) labeled HUVECs (red channel) illustrating 
the utility of the fluorescent channel for cell tracking. 
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Fig. 5 Figure 5:  Analysis of perfusion and vessel maturity in the in vivo graft 
microenvironment. (a) Baseline blood flow map (normalized to the maximum 
flow across all samples). (b) Normalized blood flow map generated by 
computing the average blood flow during the carbogen inhalation periods. (c) 
Map of the percent change in blood flow induced by carbogen inhalation. More 
mature blood vessels exhibit larger changes in blood flow. Note only positive 
changes are displayed. (d) LSC image indicating ROI (red circle) corresponding 
to the blood flow time course in (e). PCL scaffold is outlined by gray circle. 
Time series were baseline corrected and only positive perfusion changes were 
plotted. The robust response to carbogen inhalation in (e) during the 240-300 s 
(blue bar) and 540-600 s (blue bar) intervals indicate the degree of maturity of 
the blood vessels within the red circle in (d). (f) Vessel classification of 
carbogen response in (c) using k means clustering. Vessels appearing as red are 
those that indicated the greatest degree in blood flow change while black 
indicates the lowest change. (g) Probability distribution function of change in 




function of vessel radii according to the same classifications in (g) and (f).  The 
lack in variability across vessel sizes indicates that radius had no effect on 
carbogen response. (i) Similar distribution as seen in (h) but with the time to 
peak of each vessel. Again, the lack in variability indicates a lack of a 
relationship between carbogen response and time to peak response following 
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CHAPTER 1: FUNDAMENTALS OF ORTHOPEDIC TISSUE ENGINEERING 
 
1.1 Bone defects and the need for orthopedic tissue engineering 
 Tissue engineering provides a powerful means for repairing defects in bone which result 
from trauma. Through the introduction osteogenic material, coupled with the appropriate 
biochemical cues, mechanical stimulation, or growth factors, tissue engineering therapeutics can 
initiate bone and vascular remodeling, facilitating the healing of bone defect sites (1-3). Such 
therapeutics have the potential to regenerate tissue in nonunion sites, and critical-sized bone 
defects, which may enable mobility and functionality in previously unusable injured areas. 
 
1.2 Preclinical models for studying bone defects 
 Traditional treatments for bone defects arising from trauma include either allogenic or 
autologous bone grafts. But these treatments do come with inherent advantages and 
disadvantages. Allogenic bone grafts incorporate the osteoconductive and osteoinductive 
properties needed to recruit progenitor cells and provide a suitable environment for bone repair 
through the transplantation of healthy tissue from a donor. However these grafts do not include 
any osteogenic material, capable of differentiating into new osteoblasts or osteocytes and include 
a risk of an immune response (4). Because autologous grafts are taken from the host, they 
prevent the possibility of an immune response, but may result in serious morbidity at the site 
from which the graft is harvested as well as limitations in tissue available for transplantation (5). 
Recently, tissue engineering has arisen as a viable alternative to circumvent the issues associated 
with these traditional bone graft treatments. Tissue engineering involves the design of custom 
scaffolds, seeded with stem cells, and biochemical factors to provide the needed 
osteoconductivity, osteogenic material, and osteoinductivity that enables bone regeneration in a 
safe and cost effective manner (5). To study the regenerative potential of tissue engineered 
scaffolds in bone defects, preclinical models become necessary. By analyzing the impact of types 
and concentrations of osteogenic materials in various tissue engineering approaches, the design 
and safety of materials can be optimized in preclinical models before translating them into 
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patients. Murine models are well suited for such bone tissue engineering purposes (6, 7) and for 
imaging stem cell facilitated vascular remodeling in vivo (8, 9). Since most tissue engineering 
studies focus on the use of human stem cells, immunodeficient mice are especially effective 
models as they do not exhibit graft rejection at the host site (10). To determine the effectiveness 
of engineering approaches in regenerating orthopedic tissue, an ideal model should focus on a 
defect that does not demonstrate spontaneous or complete healing without the aid of treatment. 
These injuries also present the greatest challenge due to a limited number of reconstructive 
options available (11) and are defined as critical-sized defects (CSD) for bone. 
1.2.1 Critical Sized Defects 
According to the international standards developed by the ASTM Standard Guide for 
Preclinical in vivo Evaluation in Critical Sized Segmental Bone Defects (F2721-09), a critical-
sized bone defect is defined as a defect from which an animal will exhibit “less than ten percent 
bony healing ten years after the initial injury without any intervention” (12). Characterizations of 
these defects vary according to animal species, age, anatomical location, and size. However, as 
an empirical rule, the length of the defect must be at least twice the diameter of the bone (13, 14). 
Critical-sized defects in murine models have been previously studied in multiple anatomical 
locations including femoral segmental defects, maxillary defects, and calvarial defects (6, 7, 15). 
For this thesis, we will focus on calvarial defects. Also known as the “skullcap”, the calvarium is 
comprised of the neurocranium, which can in turn be divided into the cranial base, 
chondrocranium, and cranial vault, and the viscerocranium (16). These regions serve to surround 
and protect the brain as well as form the base structures for the facial skeleton. Due to the 
anatomical location of this site, typical critical-sized defects used to study tissue engineering-
based bone formation include four millimeter (4 mm) circular defects (17, 18). 
 
1.3 The relationship between angiogenesis and osteogenesis 
Angiogenesis and osteogenesis are closely coupled processes during tissue regeneration. 
The co-localization of blood vessels and osteoprogenitor cells allows for the creation of suitable 
metabolic and biochemical environments that enable enhanced progenitor cell survival, 
proliferation and differentiation (19). Additionally, blood vessels provide the nutrient and 
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oxygen deposition needed to foster bone growth (20). In animal models, vascular endothelial 
growth factor (VEGF), a key signaling protein for guiding the branching and anastomosis of 
developing vessels, has also been shown to enhance osteogenesis in low doses (19, 21). 
Recently, the identification of a new blood vessel subtype, Type H, in the metaphysis region of 
long bones has elucidated some of the previously unknown signaling steps in angiogenesis-
osteogenesis cascade. The type H endothelial cells that make up these blood vessels have been 
found to mediate growth of local vasculature and upregulate important osteogenic factors 
through the Notch signaling pathway (22). For these reasons, tissue engineering approaches 
should seek to facilitate remodeling of both, the damaged vascular network and bone reformation 
when treating critical-sized defects. 
 
1.4 Tissue engineering approaches and regenerative medicine 
The goal of tissue engineering and regenerative medicine is to stimulate the body’s 
natural regenerative capabilities through the introduction of mechanical or biochemical factors 
and to provide suitable angiogenic and osteogenic material to reform and replace lost tissue. For 
this reason, nearly all tissue engineering approaches now incorporate stem cells. 
1.4.1 Stem Cell Overview 
Stem cells are a powerful means regenerating lost tissue due to their availability and 
capacity to differentiate into nearly any cell type if provided with the proper environment and 
growth factors (23). Stem cells can be categorized into three types based on their source: adult 
stem cells, embryonic stem cells (ESCs), and induced pluripotent stem cells (iPSCs). Types of 
adult stem cells include hematopoietic, mesenchymal, neural, epithelial, adipose and skin stem 
cells (24). Embryonic stem cells are derived from the inner cell mass of an embryo 3-5 days after 
fertilization, and exhibit potential to differentiate into almost any cell type (25). More recently, 
human umbilical vein endothelial cells (HUVECs) have also been resected from the endothelium 
of umbilical cord veins after childbirth and used in tissue engineering approaches because of 
their potential to regulate angiogenesis through interactions with other enzymes and small 
binding proteins (26). IPSCs are stem cells created in the laboratory setting through the 
introduction of embryonic genes into a somatic cell, causing them to revert back to a pluripotent 
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state (27). Their source origin and therefore varying phenotype is commonly identified using the 
antigen binding of markers to cell surface glycoproteins, classification determinants (CDs). 
When designing tissue engineering approaches, the type of stem cell must be chosen carefully 
because different stem cell subtypes will more readily differentiate into subsequent lineages 
when given stimulatory factors. Many tissue engineering approaches that seek to promote bone 
reformation use mesenchymal stem cells (MSCs) due to their osteogenic properties and high rate 
of differentiation in the presence of osteoconductive materials such as bone morphogenetic 
protein (BMP) (28, 29). More recently, adipose-derived stem cells (ASCs) have also been 
investigated as a potential source of osteoconductive material due to their osteogenic potential 
and wider availability compared to MSCs (30). 
1.4.2 Current treatment methods for critical-sized segmental bone defects 
Standard treatment procedures for critical-sized, segmental bone defects involve the use 
of either autografts through vascularized bone transfer or cortical and cancellous bone allografts. 
However, these approaches are not without serious limitations such as donor site morbidity, a 
limited supply of graft tissue material, risk of an immune response and variable graft efficacy 
due to differences in donor bone quality (31). Due to the challenge associated with treating 
critical-sized defects, and the disadvantages of these traditional methods, limited efficacy has 
been seen in long term follow up studies of patient trials (32, 33). As such, there is a clear need 
for tissue engineered therapeutics that circumvent issues associated with conventional grafts and 
permit the healing of severe orthopedic tissue injuries. In this thesis, we aimed to characterize the 
vascular remodeling within a critical-sized defect in the calvarial region of mice implanted with a 
3D printed polycaprolactone (PCL) scaffold seeded with human ASCs embedded in a fibrin gel 
medium. To analyze this vascular remodeling, we imaged the defect site two weeks after scaffold 
implantation using a custom built multimodal imaging system. Our system enabled intrinsic 
optical signaling (IOS) imaging, fluorescence (FL) imaging, and laser speckle contrast (LSC) 
imaging during a single experimental session in order to provide information on various aspects 
of angiogenesis. These imaging methods will be described in detail in Chapter 2. A setup of our 






Fig. 1: In vivo imaging of the calvarial defect model. (a) Benchtop multi-contrast optical 
imaging system used to acquire in vivo images of the microenvironment of engineered 
scaffolds implanted in a calvarial defect model. (b). Diagram of the calvarial defect area 
location on a mouse skull. (c) Superior view of a 3D-printed polycaprolactone scaffold 
implanted in the calvarial defect. (d) Magnified view of 4 mm 3D printed scaffold seeded with 
ASCs suspended in a fibrin gel. (Calvarial Diagram adapted from: Zhang W, Zhu C, Ye D, Xu 
L, Zhang X, Wu Q, et al. Porous Silk Scaffolds for Delivery of Growth Factors and Stem Cells 





CHAPTER 2: IMAGING TECHNIQUES FOR VISUALIZING VASCULAR AND BONE 
REMODELING 
2.1 In vivo vs. Ex vivo Imaging 
Imaging is a powerful tool for characterizing the extent of bone and blood vessel 
regeneration in clinical and preclinical tissue engineering applications. By visualizing the 
angiogenic vascular network and bone formation in the defect site, we can quantitatively assess 
the effect of the stem cell mediated therapy on wound healing at the injury site. This section 
describes the types of imaging modalities that can be used as well as the quantitative information 
that can be extracted from each modality. One could employ in vivo or ex vivo imaging methods 
to assess angiogenesis and osteogenesis in preclinical bone injury models. In vivo imaging is 
advantageous in such models because it allows for the visualization of the native environment 
with minimal disturbance to the site. Additionally, in vivo imaging techniques provide important 
information about the dynamic characteristics of blood vessels during the angiogenic process. 
Since visualization of vessels and bone is often limited by the penetration depth of incident light, 
maintaining spatial resolution at increased imaging depths becomes challenging (34). Ex vivo 
imaging techniques can be advantageous in studying preclinical models because they often 
include staining and clearing techniques that improve visualization of the sample and allow for 
the clear distinguishing of vascular structures, often in 3D (35). Recently, ex vivo samples have 
been used to study retinal angiogenesis in mice (36). The disadvantages of ex vivo imaging stem 
from the fact that they require excision of the imaged samples, which may damage the tissue. 
Additionally, ex vivo imaging cannot be used to study vascular perfusion and the scope of 
experiments can be limited by the amount of time required to perform the optical clearing and 
staining of tissue samples. For the purpose of our studies, we chose to utilize in vivo imaging 
techniques to avoid the damage that can occur to tissue samples during excision or tissue 





2.2 Imaging vascular morphology 
To assess vascular remodeling in bone defect sites, imaging techniques that enable 
visualization at microvascular spatial resolution (~5-10 µm) are needed. Such techniques include 
widefield and confocal microscopy, intrinsic optical signaling, multiphoton microscopy, optical 
coherence tomography (OCT), and micro-computed tomography (micro-CT). Optical imaging 
techniques often include optical sectioning to provide depth-resolved 3D images along with the 
administration of fluorescent dyes to augment visual contrast. 
2.2.1 Optical sectioning techniques 
Optical sectioning is not its own type of imaging modality, but instead a process by 
which 3D structures can be visualized without the need for physical sectioning of the tissue 
being imaged into thin slices. By removing the out-of-focus light within images across multiple 
focal planes, optical sectioning provides much greater contrast and allows for 3D reconstruction 
of specimens via the combination of all image planes into a single stack of images (38). This 
process is implemented in many types of optical imaging such as standard confocal, line 
scanning, spinning-disk, and multiphoton microscopy in order to increase resolution along the z 
axis, and is commonly implemented by introducing a pinhole aperture. By placing a pinhole 
aperture in front of the detector, most of the scattered and out-of-focus light can be eliminated 
without impeding the light from the desired in-focus plane (38). As such, the pinhole’s 
effectiveness is directly correlated to its size and must be chosen carefully to maintain 
effectiveness without compromising the difference in brightness between the signal and the 
background that is needed to distinguish structures. Optical sectioning techniques have recently 
been utilized to study regeneration in rat femoral defects (39) and angiogenesis in critical-defects 
within the calvarial region of mice (40) using multiphoton microscopy. 
 
2.2.2 Widefield and confocal microscopy 
Widefield and confocal microscopy are similar imaging techniques which deliver 
fluorescent excitation light through on objective lens onto the target specimen (41). As 
previously mentioned, the main difference between these two techniques stems from the fact that 
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confocal microscopy uses a pinhole aperture where widefield does not. As such, widefield 
microscopy enables visualization of whole samples whereas confocal only allows image capture 
of a single focal spot at a time. This narrower field of view comes with the benefit of drastically 
increased spatial resolution, optical sectioning and image contrast. Laser confocal microscopy 
has been used to characterize electrospun fibrous membranes for bone defect repair (42). While 
not commonly employed in studying tissue defects, widefield microscopy has been used to 
image microvasculature in mice in order to monitor thrombus formation (43). 
 
2.2.3 Intrinsic Optical Signaling, Multiphoton, OCT, and micro-CT 
Intrinsic optical signaling is an imaging technique that relies on a endogenous contrast 
mechanisms in native tissue to produce images that may be used to study morphological 
characteristics of vessels. As such, it can be used to visualize vascular networks without the need 
for dye administration, which requires an injection and may disrupt the normal blood flow 
patterns, and therefore the morphological observed characteristics. In biological systems, IOS is 
based on the differential absorption spectra of oxy- and deoxyhemoglobin (44). At an excitation 
wavelength of 573 nm, an isobestic point between oxygenated and deoxygenated hemoglobin 
can be observed. Therefore at 573 nm, since the absorption coefficients of oxygenated and 
deoxygenated hemoglobin are approximately equivalent, both components can be visualized 
together as total hemoglobin. Since hemoglobin is physiologically compartmentalized to the 
blood vessels, images acquired under 573 nm illumination make the blood vessels appear as dark 
structures against the grayscale background of the surrounding tissue. While IOS has been used 
to image the vascular networks in cerebral regions of mice and monkeys (45, 46), such 
techniques have not been used to observe vascular remodeling in bone defect sites. 
 Multiphoton microscopy is a fluorescence imaging technique that enables the imaging of 
live tissue up to a depth of approximately 1 mm (47). Multiphoton microscopes rely on “high-
order nonlinear light-matter interactions, where multiple photons are required for contrast 
generation” (48) As such, the localization of excitation in photons results in greatly improved 
penetration depths and minimized photobleaching or photodamage to the specimen. Two-photon 
fluorescence is the most commonly employed multiphoton microscopy technique, however other 
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methods such as second harmonic generation, three-photon fluorescence, and even four-photon 
fluorescence do exist (48). Multiphoton microscopy is primarily used to visualize cells in 
immuno-oncology studies (47, 49) however it has recently been used to analyze tissue 
engineered scaffolds seeded with MSCs for diabetic wound healing (50) as well as angiogenesis 
in critical-sized defects of the calvarial region (51). 
 Optical Coherence Tomography is a well-studied imaging technique with applications 
ranging from animal studies to neurosurgical and tumor diagnostic tools (52). OCT utilizes the 
reflection of relatively low-wavelength light off biological tissue in a cross-sectional plane to 
produce high resolution images (53). Similar to multiphoton microscopy, OCT can be used for 
cellular and even subcellular level resolutions depending on the coherence length of light source 
used. OCT has also been used to map vascular networks in the cerebral regions of animal models 
(54, 55). 
Micro-Computed Tomography is an x-ray transmission imaging technique that uses 
multiple 2D image slices to reconstruct a 3D visualization of the target specimen (56). It is a 
widely used technique in tissue engineering applications for its ability to image both blood 
vessels and bone structures on a micron scale. μCT has recently been used to image rhBMP-2 
mediated segmental bone defect repair in murine models (57) as well as angiogenesis during 
bone regeneration in both non-critical (58) and critical-sized defects in the calvarial region of 
mice (59). 
 
2.3 Monitoring Hemodynamic Response 
 To determine the success of tissue engineering treatments in repairing orthopedic trauma 
is it important to evaluate not only the morphology of the newly regenerated vessels, but also 
their functionality. As such, complementary imaging modalities are needed in order to provide 
information on the hemodynamic response within defect sites. Commonly used methods that will 
be discussed in this section include laser speckle contrast (LSC) imaging, dynamic contrast 
enhanced-magnetic resonance imaging (DCE-MRI), and dynamic susceptibility contrast-
magnetic resonance imaging (DSC-MRI). Additionally, we will discuss the administration of 
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vasodilators during the course of blood flow imaging in order to assess vascular maturity and 
compliance. 
 
2.3.1 LSC, DCE-MR, and DSC-MR Imaging 
Laser speckle contrast imaging relies on the interference pattern that results when 
biological tissue is illuminated by a coherent light source (60). Tissue that contains blood vessels 
display particular interference patterns due to the movement of red blood cells through the 
vascular network. As such, blood vessels can be easily identified from the surrounding tissue, 
and the recorded interference or ‘speckle’ pattern integrated over a finite exposure time to 
produce maps of the relative blood flow values over the entire field of view (61, 62). LSC 
imaging has been previously used to monitor in vivo blood flow in cerebral (63) and retinal (64) 
areas in murine models. However, to the best of our knowledge it has not yet been used to map 
hemodynamic changes in tissue engineering applications. 
DCE and DSC MRI are similar imaging techniques that require administration of a 
paramagnetic contrast agent in order to visualize hemodynamic responses in vascular networks. 
Gadolinium chelates are commonly used for both methods (65). DCE focuses on quantifying the 
permeability of blood vessels by measuring the leakage of the contrast dye from the vasculature 
using T1-weighted MRI, while DSC can be used to estimate vessel density and blood volume in 
the vascular network using T2 and T2*-weighted MRI (66). These techniques are used to image 
perfusion in tumors (67), or in areas of the brain affected by strokes (68). However recently, 
DCE-MRI has also been employed to monitor angiogenesis in tissue engineering constructs for 
calvarial bone regeneration (69). 
 
2.3.2 Administration of vasodilators to map vascular maturity and compliance 
Vasodilatory agents can cause vasodilation of blood vessels, resulting in increased blood 
flow and blood volume in the region of interest (70). Frequently used vasodilators in preclinical 
studies include prazosin, verapamil, cromakalim, and carbogen gas (71, 72). Regardless of the 
method chosen, the effect on the vascular network is similar. Each serves to slightly alter the pH 
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of the environment. This change in pH causes relaxation of the smooth muscle surrounding 
blood vessels, allowing them to dilate and prompting increased blood flow (73). Since smooth 
muscle takes time to develop around the newly formed vessels in a bone defect site, the 
administration of vasodilators can inform on the relative maturity of the blood vessels present. 
 
2.4 Vascular tracer kinetics and stem cell tracking 
 To further characterize vascular hemodynamics within an angiogenic vessel bed, 
alternative imaging modalities may be implemented. Fluorescence imaging is well suited for 
assessing the tracer kinetics of fluorescent dyes passing through vessel networks (74), while 
positron emission tomography (PET) may be used to create 3D reconstructed visualizations of 
nuclide tracers (75). Additionally, because cells can be fluorescently tagged, bleached, or 
transfected to display fluorescent proteins, fluorescence imaging can be used to track stem cells 
and monitor their differentiation (76, 77). 
 
2.4.1 Fluorescence Imaging 
Fluorescence imaging is the visualization of fluorescent dyes or proteins and has a wide 
range of applications from guiding medical diagnostics (78) to measuring vascular characteristics 
(74). Fluorescence imaging has been previously utilized to assess the integration of tissue 
engineering grafts in mice (79) in addition to the tracking of induced pluripotent stem cells (76). 
 
2.4.2 Positron emission tomography 
Positron emission tomography (PET) uses computer analysis to reconstruct images of 
gamma rays given off by positron emitting radionuclide tracers as they transit blood vessels in 
the target tissue (80). While often used for oncology diagnostic purposes (75), these 3D 
reconstructed maps have recently been used to analyze the stem cell mediated repair of 
segmental long-bone defects (81), and track human muscle precursor cells for the purpose of 




2.5 Bone Visualization 
 In addition to imaging the morphological, hemodynamic, and tracer kinetic 
characteristics of vascular networks in bone defect sites, the volume of regenerated bone can also 
be used as a metric for treatment success. To determine the amount of regrown bone, several 
other imaging modalities including x-ray imaging, micro-computed tomography (μCT), MRI, 
and ultrasound imaging can be used. In this section, we will review each method’s capabilities 
generating images of bone in vivo. 
 
2.5.1 X-ray (radiography) and Micro-Computed Tomography 
X-ray imaging is one of the oldest imaging techniques and uses electromagnetic radiation 
to produce 2D images of dense biological tissue. Electromagnetic waves are projected into the 
specimen and are absorbed by increasing amounts based on the density of the material they come 
into contact with. By placing a detector behind the specimen, any x-rays that pass through the 
specimen can be captured and used to produce images of the darker areas (e.g. bone) surrounded 
by less dense areas (e.g. blood and tissue) (83). μCT can be considered a direct advancement of 
x-ray imaging as this method uses the same principles but incorporates multiple 2D images at 
varying angles to produce a 3D reconstructed visualization of bone areas (56). μCT has been 
used in recent years to study bone formation around bioactive scaffolds in noncritical-sized 
defects within the mandibles of pigs (84), and to visualize bioactive glass foam scaffolds 
implanted into the legs of mice (56). 
 
2.5.2 Ultrasound Imaging 
Modern advancements in ultrasound techniques have enabled it to become a viable 
alternative to the traditional x-ray and μCT imaging of bone (85). Instead of monitoring the 
behavior of light or electromagnetic radiation when passing through biological tissue, ultrasound 
measures the absorbance and scattering of high frequency (~MHz) sound waves (86). The 
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specific type of ultrasound used to visualize bone is known as quantitative ultrasound and uses 
lower frequencies (4-10 MHz) which correlate to the density and composition of bone. As such, 
ultrasound has been used successfully to evaluate fracture healing in bone defects, even showing 




CHAPTER 3: EXPERIMENTAL PROTOCOL AND IMAGING PROCESSING 
 
3.1 3D scaffold fabrication 
 
For the purpose of our tissue engineering experiments we created porous 3D-printed PCL 
scaffolds using a LulzBot TAZ printer with a 375 μm diameter nozzle (Aleph Objectives, Inc.; 
Loveland, CO). Scaffold sheets with 0.5 mm thickness, 30% infill density, and rectilinear infill 
pattern were designed, sliced, and converted to G-code using Cura software (Ultimaker B.V.; 
Geldermalsen, Netherlands). PCL scaffold sheets were printed according to the G-code using an 
extrusion and cooling bed temperature of 105°C and 45°C, respectively. Cylindrical scaffolds 
were punched from the sheets using a 4 mm diameter drill bit. Prior to cell culture studies, 
cylindrical 3D-printed scaffolds were treated with 1 M NaOH for 1 h to increase surface 
hydrophilicity and washed 3 x 10 min in PBS. Scaffolds were then sterilized in 100% ethanol for 
1 h, followed by 3 x 20 min washes in sterile PBS. One day prior to seeding, scaffolds were 
incubated in stromal medium (DMEM, 10% v/v FBS, 1% v/v P/S) at 37°C overnight to allow for 
serum proteins to adsorb to the scaffold surface. 
 
3.2 Stem cell isolation and calvarial defect preparation 
 
Lipoaspirate from a Caucasian female donor (39 y.o.) was obtained from Johns Hopkins 
Medical Institutions under an approved Institution Review Board protocol. To isolate adipose-
derived stem cells (ASCs), lipoaspirate was digested with 1 mg/mL Collagenase I (Worthington 
Biochemical Corp.; Lakewood, NJ) at 37°C for 1 h and centrifuged at 300 g for 10 min to obtain 
a pellet of stromal vascular fraction. Following cell resuspension, RBCs were removed by lysing 
RBCs in a buffer (155 mM NH4Cl, 10 mM KHCO3 and 1 mM EDTA) for 7 min and 
centrifuging at 300 g for 5 min. The stromal vascular fraction pellet was resuspended and plated 
onto T-175 flasks to allow for expansion of the adherent ASC population. ASCs were expanded 
using expansion medium (DMEM, 10% v/v FBS, 1% v/v P/S, 1 ng/mL FGF-2) for two passages 




3D-printed scaffolds were then seeded with ASCs encapsulated within a fibrin gel as 
previously described (87). P2 ASCs were trypsinized and resuspended in 10 mg/mL fibrinogen at 
a density of 25 x 106 cells/mL. Thrombin (10 units/mL) was added to the ASC-fibrinogen 
mixture (1:4 v/v) to yield a cell concentration of 20 x 106 cells/mL, and 6 μL of the solution was 
infused into the pore spaces of 3D-printed scaffolds. Scaffolds were incubated at 37°C for 30 
min to allow for fibrin to completely crosslink prior to adding culture medium. Scaffolds were 
incubated in stromal medium overnight prior to in vivo implantation.  
 
All animal procedures were approved by the Johns Hopkins Animal Care and Use 
Committee (JHU ACUC). Male 11-week-old homozygous Nu/J mice (Jackson Laboratories; Bar 
Harbor, ME) were anesthetized using isoflurane and injected subcutaneously with 0.2 mg/kg 
buprenorphine (Reckitt Benckiser Pharmaceuticals, Inc.; Slough, UK) prior to surgery. After 
sterilizing skin at the surgical site with betadine, an incision was made to expose the calvarium, 
and the pericranium was gently removed to allow for drilling of the defect. A 4-mm diameter 
defect was drilled in the right calvarium using an Ideal Micro-Drill (Harvard Apparatus; 
Holliston, MA) and 4 mm circular knife (Xemax Surgical Products, Inc.; Napa, CA). Special 
care was taken to avoid disrupting the underlying dura mater. Scaffolds were implanted by 
briefly washing them in sterile 0.9% NaCl and press-fitting them into the defect. The incision 
was then sutured using 6-0 nylon sutures to close the surgical wound. Animals were treated with 
an intraperitoneal injection of 0.2 mg/kg buprenorphine twice a day for 2 days following surgery 
for pain management. 
 
3.3 Multimodal Imaging Acquisition 
 
 To image microvascular structure and function in the scaffold and tissue 
microenvironment, we used a minimally invasive multicontrast optical imaging setup. This 
imaging system acquires high temporal (10 fps) and spatial resolution (5 μm) images, and is 
capable of three imaging modalities: intrinsic optical signal (IOS), laser speckle contrast (LSC) 
and fluorescence (FL) imaging. . Fig. 2 summarizes the microenvironmental parameters obtained 




We used a white light 
source (NI-150, Nikon 
Instruments Inc., NY) coupled 
with two band-pass filters (560 
and 570±5nm) to provide 
illumination for IOS imaging 
along with a filter wheel 
(FW102C, Thorlabs,NJ). A 
632.8 nm HeNe laser (0.5mW, 
Thorlabs, NJ) was used to 
acquire LSC images, and a 
473 nm laser (100mW, Cobalt 
AB, Sweden) along with a 496 nm long-pass filter (FF01-496/LP-25, Semrock Inc.,NY) was 
used for acquiring fluorescence images. Mice were first anesthetized using a controlled flow rate 
of 1.5% isoflurane (Iso Flo, Cat. No. 06-8550-2/R1) in 1L/min air with a Vapomatic Model: 2 
(AM Bickford Inc., NY) before being placed on an adjustable platform with their heads secured 
in place using a custom designed stereotaxic frame. A multi-lens set (AF Micro Nikkor 60mm 
1:2:8D, Nikon Instruments Inc., NY) was used for image acquisition at 0.5 magnification using a 
CCD camera (Infinity 3, Lumenera, ON, Canada) controlled by a customized MATLAB® 
(MathWorks; Natick, MA) program. IOS images were used to characterize in vivo changes in 
microvascular morphology and fluorescence images were used to detect RFP-tagged cells and 
intravascular FITC conjugated dextran (70 kD). Lastly, we employed LSC imaging for analyzing 
perfusion changes and microvessel maturity within the scaffold microenvironment. 
 
3.3.1 IOS 
 For IOS, the governing equation was developed from a modified version of the Beer-
Lambert’s Law (44) as shown in Eq. 1. Here the logarithmic ratio of the incident light (Io) and 
the reflected light (Iα) divided by the length traveled by the light (L) is equal to the absorption 
coefficient (μ) multiplied by the concentration of both oxygenated and deoxygenated 
hemoglobin. 
Fig. 2: Multi-contrast in vivo imaging of the graft microenvironment. 
Flow chart illustrating key microenvironmental factors that are interrogated 
in vivo (green) within the calvarial defect site; the in vivo optical contrast 
mechanism employed (red) to assay these factors; the imaging method 
employed (blue), and the metrics computed for characterizing the in vivo 
graft microenvironment. * Can also be used to track fluorescently labeled 









=⁡𝜇𝐻𝑏𝑂(𝛾) ∙ [𝐻𝑏𝑂] + 𝜇𝐻𝑏(𝛾) ∙ [𝐻𝑏] (1) 
At the isobestic point of 570nm, where the absorption coefficients of oxygenated and 
deoxygenated hemoglobin are approximately equal, one can reduce Eq. 1 to Eq. 2. 
𝑙𝑛(𝐼𝑜) − 𝑙𝑛(𝐼𝛼) ⁡∝ 𝐻𝑏𝑇 (2) 
Therefore, if we consider background pixels within our image to be points where nearly all light 
is reflected then the images we capture show background tissue as bright since they lack 
hemoglobin and blood vessels appear dark, since they are hemoglobin rich structures. For our 
experiments, IOS images were acquired at 10 fps with an exposure time of 60 ms. 
 
3.3.2 FL 
 For FL tracer experiments, 0.2 mL of 10 mg/mL 70 kD dextran-FITC was administered 
through a tail-vein injection. The transit of FITC through the microvascular bed at the graft site 
was then imaged under blue laser (i.e. 473 nm) illumination at 10 fps with an exposure time of 
150 ms for ~3 min. 
 
3.3.3 LSCI 
For LSC, speckle fluctuations or the degree of ‘blurring’ was quantified using Eq. 3 (88). 
Acquiring a temporal stack of the speckle pattern with a CCD camera over a given exposure time 
allows us to quantify the degree of blurring, which is inversely proportional to the relative 
perfusion. Each pixel in our FoV was assigned a speckle contrast or K value, which was the ratio 
of the standard deviation, σ, to the mean pixel intensity, <I>, where K
2
 is inversely proportional 
to the moving object’s flow velocity. For each pixel, a moving average was calculated in order to 




, 𝐾2 ⁡ ∝ ⁡
1
𝑉
  (3) 
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The variance of the time-averaged pixel intensity was equal to its temporal fluctuations and is 
given by Eq. 4, below (62). Here, T is the camera exposure time, c  is the temporal average of 







𝑑𝜏  (4) 
Using LSC, we also employed a carbogen gas challenge to assess the in vivo hemodynamic 
response and map vessel maturity. Carbogen gas, a mixture of 95% oxygen and 5% carbon 
dioxide, increases cerebral blood flow via vasodilation (71). At a microvascular level, increased 
oxygen delivery causes changes in tissue perfusion, which alters vascular resistance and 
perfusion pressure (89). Carbon dioxide causes a decrease in pH within the blood which is 
detected by receptors in the vessels walls that then cause the vessel smooth muscle to relax, 
resulting in vasodilation (90). In our protocol, mice were administered alternate cycles of room 
air and carbogen gas in 3 minute and 30 second blocks respectively, and LSC image stacks were 
acquired during the entire experiment. The raw speckle data was smoothed using a 10×10 pixel 
median filter, and a 33 pixel temporal Gaussian filter to reduce noise and increase the signal to 
noise ratio (SNR) of the LSC images. Images were acquired at 10 fps with an exposure time of 
60 ms. 
 
3.4 Image Processing Methods 
  
Prior to analyzing our acquired image stacks, a number of resampling, registration, 
smoothing, filtering, and thresholding steps were required. In this way, we were able to generate 
clear ‘vessel masks’ which could then be used to study the vascular morphology, tracer kinetics, 
and hemodynamics of our newly regenerated vessel beds. 
 
3.4.1 Resampling Fixed Time Points and Image Registration  
 
For processing of FL images, the acquired image stack was first imported into MATLAB® 
and resampled using linear interpolation to create image stacks with 50 ms temporal resolution. After 
acquiring image stacks using IOS, LSC, and FL imaging, image processing was performed using 
ImageJ (91) and MATLAB®. Image stacks from each imaging modality were co-registered 
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using the ImageJ plugin TurboReg (92). This allowed us to directly compare microvascular 
parameters across each modality. 
 
3.4.2 Smoothing, Gaussian, and Low-Pass Filters 
 
For IOS and LSC images, maximum intensity projection (MIP) images of each image 
stack were generated and corrected for non-uniform illumination using a rolling ball background 
subtraction of 50 pixels in radius. FL image stacks were subjected to a low pass filter at a cutoff 
frequency of 1 Hz to remove ‘spot’ noise 
 
3.4.3 Gaussian and Hessian Filter for distinguishing vessels 
 
Next, blood vessels were segmented using an ImageJ plugin called a ‘tubeness’ filter that 
distinguishes curvilinear or tubular structures such as blood vessels, bronchi or neurons by 
computing the 3D Hessian (93). The plugin employs Gaussian convolution with standard 
deviation, σ, which we varied to segment blood vessels of different radii. We selected three σ 
values ranging from 0.5-3 for each IOS MIP image in order to segment every vessel. 
Subsequently, IOS output images from the tubeness filter were combined using a ‘maximum’ 
operator while LSCI output images were combined using an average intensity projection of the 
baseline blood flow stack. This step was necessary to preserve blood vessel morphology because 
blood vessels dilated during administration of the carbogen gas. 
 
3.4.4 Thresholding and Particle Filtration  
 
After producing maximum and average intensity projections of our image stacks, these 
output images were thresholded to yield binary ‘vessel masks’. Next, morphological operations 
such as image opening and closing were used to restore portions of blood vessels lost during the 
thresholding step. Finally, any residual noise outside the graft area was removed using a 
minimum size filter of 10 square pixels to yield the final blood vessel masks. Finally, the IOS 
and LSC derived blood vessel masks were combined to yield an overall mask that allowed us to 





3.4.5 Euclidean Distance Maps and Tagged Skeletons 
 
Next, we generated a tagged skeleton and a Euclidean distance map (EDM) of the overall 
blood vessel mask using ImageJ. A tagged skeleton is an image wherein the morphology of the 
segmented blood vessels is represented as single pixel-wide branches along their centerline. 
These pixels were then classified based on the number of connected neighbors as ‘end points’ or 
‘junctions’ (94). The tagged skeleton image can therefore be used to identify branch points in the 
microvascular tree, the total number of vessels present, and assess vessel length. The Euclidean 
distance map computed from our overall vessel mask replaces background pixels with grayscale 
values corresponding to their distance from the nearest blood vessel boundary (95). Therefore, 
when logically combined with the tagged skeleton, the EDM can be used to represent the average 
radii of all vessel segments in the overall blood vessel mask. This approach yields maps of the 
blood vessels within the graft site coded by their morphological parameters (i.e. vessel radii, 
vessel length, and tortuosity) and depict valuable information that can be used to quantify 
angiogenesis at the graft site. 
 
To assess the relative blood flow within the vessels permeating our scaffold, we began by 
using the aforementioned methods for determining and mapping vessels within the overall mask. 
Next, we created average intensity projection images from the baseline blood flow (i.e. LSC) 
time series over 12 min, as well as the blood flow time series during carbogen gas experiments 
(i.e. three cycles of air for 3.5, 5.5, and 4.5 min interspersed with two cycles of carbogen gas 
inhalation for 1 min). By utilizing the vessel segment information from the tagged skeleton 
image, the blood vessel dimensions from EDM images and computing the grayscale pixel 
intensity from the average projection images, we were able to map the relative blood flow per 
vessel segment. In order to more easily compare the baseline and carbogen blood flow values, 
we normalized these data by dividing the grayscale intensity values assigned to each vessel 
segment by the maximum value that occurred across all LSC trials during the carbogen 
inhalation experiment, resulting in a relative blood flow value scaled between 0 and 1. To assess 
the change in blood flow in response to carbogen gas inhalation, the percent increase in the 
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average pixel intensity per vessel segment between baseline air and carbogen inhalation states 
was computed and mapped to the overall vessel mask. By quantifying carbogen gas-induced 
changes in blood flow we could quantify the relative maturity of each vessel segment within the 
angiogenic graft site. These changes correspond to fluctuations in blood flow caused by 
vasodilation in mature blood vessels. 
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CHAPTER 4: ANALYZING VASCULAR REMODELING DATA 
 
After processing out images and creating vessel masks, we used a k-means clustering 
approach implemented in MATLAB® to classify each vessel segment based on its change in 
blood flow during carbogen gas inhalation. The input to the k-means clustering was an array 
containing the flow values of each vessel segment and the output was a list of four classes that 
partitioned these flow values based on their nearest means. The index values allocated to these 




 Using IOS and LSC images of the calvarial defect site (Fig. 3a, b) we generated binary 
vessel masks derived from each modality (Fig. 3c, d), which were combined to create an overall 
mask (Fig. 3e) that was used to analyze all morphological parameters. With the tagged skeleton 
Fig. 3:  Analysis of vascular morphology in the in vivo graft microenvironment. (a) IOS image of the calvarial 
defect site two weeks after implantation wherein the vasculature is dark due to green light absorption. PCL scaffold 
is outlined by the gray circle.  (b) LSC image of the same FoV wherein perfused blood vessels appear bright due to 
red laser light being scattered by moving erythrocytes. PCL scaffold is again outlined by a gray circle. (c, d) Images 
in (a, b) overlaid with their respective binary vessel masks. (e) Combination of the vessel masks in (c, d) to provide 
a holistic mask of all the vessels that are visible using either imaging method. (f) Map of the average vessel radius 
corresponding to the vessel segments identified in (e). (g, h, i) Distribution of vessel characteristics for the sample 




and EDM derived from the overall mask we were able to visually represent characteristics of the 
vascular network as shown in Fig. 3f. Here we can see that there was a wide range of vessel radii 
distributions within the scaffold site. The minimum measureable radius was 5.6 μm due to the 
resolution of the camera sensor and optics. Fig. 3g, Fig. 3h, and Fig. 3i show the distributions of 
vessel characteristics assessed from the overall vessel mask (Fig. 3e). For the distribution shown 
in Fig. 3g the average vessel length was 93.4 μm with the most frequently occurring bin falling 
between 20-40 μm and a maximum vessel length of 793.1 μm. Similarly, from Fig. 3h we see 
the most frequent range of vessel tortuosities was between 0.7-1 with an average of 1.22 and a 
maximum 4. Additionally from Fig. 3i, the most frequent range of vessel radii was from 16-17 
μm with an average of 16.6 μm and a maximum of 40.2 μm which matched the values displayed 
in the vessel map (Fig 3f). This morphological data regarding the blood vessels within the graft 
site provides invaluable information regarding angiogenesis within the scaffold. Furthermore, 
these measurements can be used to characterize the vessel phenotypes as described in the 
Discussion. 
 
 From the image stacks of the dextran-FITC injections obtained using FL imaging we 
were able to clearly observe the transit of the tracer through the vascular bed (Fig. 4a) within the 
graft site. To illustrate the first-pass of dextran-FITC through the microvasculature, we plotted 
the mean fluorescent signal intensity of from a sub-region (Fig. 4b) wherein one can clearly 
observe the wash-in and wash-out of the tracer and the contribution of individual time points to 
the overall tracer curve. By importing the image sequence into MATLAB we could determine 
the time-to-peak value per vessel segment and map these values to our overall vessel mask (Fig. 
4c). Finally, using FL imaging we were also able to capture the distribution of HUVEC tagged 




From the overall vessel mask and the average intensity projections during air and 
carbogen breathing blocks, we were able to map changes in blood flow within the microvascular 
network at the graft site (Fig. 5a, b). In order to compare measurements, these values were 
normalized to the highest recorded blood flow value across all experiments. Using these 
normalized blood flow maps, we calculated the percent change in blood flow due to carbogen 
inhalation (Fig. 5c). Blood flow changes as high as 25% were observed in some vessels. In order 
to more closely analyze the blood flow response, we plotted the percent change in blood flow for 
a single vessel (Fig. 5d) over the course of the carbogen inhalation experiment as shown in Fig. 
5e. Here we can see that blood flow in the target vessel responded clearly and consistently during 
the carbogen inhalation blocks. Finally, using a k-means clustering approach we classified each 
blood vessel based its magnitude of blood flow change (Fig. 5f, g) and then applied the same 
cluster class to additional vessel characteristics in order to ascertain the relationship between 
parameters such as vessel radii or TTP and the observed change in blood flow. As shown in Figs. 
Fig. 4:  Analysis of tracer kinetics and cell distribution in the in vivo graft microenvironment. (a) 
Representative time series of fluorescent images acquired after injection of the fluorescent intravascular tracer 
FITC-dextran. PCL scaffold is outlined by the large gray dashed circles.(b) Plot of the fluorescence intensity from 
the ROI (red circle) in (a) illustrating the transit of the intravascular tracer through the vasculature within the graft. 
Red points correspond to the time points for which snapshots are shown in (a). (c) Time-to-peak (TTP) map 
computed from the tracer data for each vessel segment within the FoV. (d) Fluorescent image of a scaffold seeded 
with a mixture of ASCs and red fluorescent protein (RFP) labeled HUVECs (red channel) illustrating the utility of 




5h and 5i, vessel radius did not correlate with the blood flow response, while the TTP in vessels 
tended to be longer for vessels that exhibited larger blood flow changes within the graft site. 
 
 
Figure 5:  Analysis of perfusion and vessel maturity in the in vivo graft microenvironment. (a) Baseline blood 
flow map (normalized to the maximum flow across all samples). (b) Normalized blood flow map generated by 
computing the average blood flow during the carbogen inhalation periods. (c) Map of the percent change in blood 
flow induced by carbogen inhalation. More mature blood vessels exhibit larger changes in blood flow. Note only 
positive changes are displayed. (d) LSC image indicating ROI (red circle) corresponding to the blood flow time 
course in (e). PCL scaffold is outlined by gray circle. Time series were baseline corrected and only positive 
perfusion changes were plotted. The robust response to carbogen inhalation in (e) during the 240-300 s (blue bar) 
and 540-600 s (blue bar) intervals indicate the degree of maturity of the blood vessels within the red circle in (d). (f) 
Vessel classification of carbogen response in (c) using k means clustering. Vessels appearing as red are those that 
indicated the greatest degree in blood flow change while black indicates the lowest change. (g) Probability 
distribution function of change in blood flow in response to carbogen as seen in (f). (h) Probability distribution 
function of vessel radii according to the same classifications in (g) and (f).  The lack in variability across vessel sizes 
indicates that radius had no effect on carbogen response. (i) Similar distribution as seen in (h) but with the time to 
peak of each vessel. Again, the lack in variability indicates a lack of a relationship between carbogen response and 






Achieving adequate vascularization in tissue engineered bone grafts is critical to their 
engraftment, long term survival and eventual clinical success. It is well known that blood vessels 
are essential for graft survival because they deliver O2 and essential nutrients, while also 
removing cellular waste products. However, vasculature is also essential for bone development 
and homeostasis, with several studies demonstrating that the coupling of angiogenesis and 
osteogenesis is necessary for bone growth and remodeling (96, 97). Additionally, the blood 
vessel phenotype plays a critical role in this process. For example, vessels that contribute to bone 
growth – termed “Type H vessels” – exhibit higher blood flow, CD31 and endomucin 
expression, and secretion of pro-osteogenic factors (97, 98), and have a thinner, more elongated 
morphology than other bone vessels (8). Furthermore, osteoprogenitors and osteoblasts are 
intimately associated with Type H vessels, typically residing within 20 μm of the nearest vessel 
(96). In light of these findings, some investigation into blood vessel phenotypes within implanted 
tissue engineering bone grafts has been performed (99). However, most current tissue 
engineering approaches do not utilize imaging techniques capable of adequately assessing the 
role of the vascular phenotype and angiogenic-osteogenic coupling in bone regeneration.  
 
Herein lies the value of our imaging system, which combines IOS, LSC, and FL imaging 
in a way that enables the robust characterization of the vasculature in tissue engineered bone  
grafts in vivo. Since our system was designed to specifically image microvascular networks in 
vivo, it avoids the disadvantages of tissue clearing approaches used for ex vivo imaging such as 
distortion of the microvascular architecture and a lack of blood flow information (37).  
Blood vessel maturity can be estimated by quantifying the degree to which blood vessels 
respond to a vasodilatory challenge, such as carbogen gas inhalation. The underlying premise 
being that this blood flow response is proportional to the degree of smooth muscle coverage that 
has developed around blood vessels at the graft site. Here, we chose to evaluate vessel maturity 
by measuring the blood flow responses during carbogen challenges with LSC imaging because it 
is less sensitive to inaccuracies such as motion within the FoV. Although one could derive such 
estimates from IOS imaging by determining changes in microvessel diameter induced by 
carbogen, such measurements are challenging since small changes in blood vessel diameter are 
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susceptible to noise resulting from subject motion. LSC imaging is not without its own 
drawbacks however, as it is difficult to determine whether blood vessels within the graft site are 
themselves responding to the carbogen or if the increased blood flow is the result of upstream 
vasodilation. Additionally, while LSCI does provide valuable information on the relative blood 
flow changes, an imaging method that permits absolute blood flow measurements would be 
preferable for certain applications.  
 
By permitting the evaluation of parameters such as vascular morphology, blood flow, and 
blood vessel maturity, our imaging system facilitates the characterization of the vascular 
phenotype. Combining this multimodal imaging platform with clustering and 
structural/functional blood vessel mapping enables us to quantify changes that accompany the 
developing or angiogenic vascular bed within a tissue engineered scaffold. Such observations are 
critical for accurately assessing the regenerative potential of bioactive scaffolds as well as for 
informing their design. Future applications of this imaging platform involve its use to understand 
the effect of vessel phenotypes on the regenerative microenvironment within the graft. 
Furthermore, quantitative comparison of these vascular phenotypes across various tissue 
engineered scaffolds would enable us to better understand the success or limitations of different 
approaches for treating critical size calvarial defects. Finally, by tracking the location of 
implanted stem cells relative to the angiogenic blood vessels, one could follow their 




CHAPTER 5: CONCLUSIONS AND FUTURE RESEARCH 
 
In this thesis, we have review the previously used bone grafts techniques used to treat 
orthopedic defects, their shortcomings, and novel approaches to improve upon defect treatment 
using tissue engineering methods. Additionally, we have reviewed an extensive list of imaging 
techniques that may be used to characterize defect sites either through visualization of bone or 
the angiogenic network during wound healing. Finally, we have described a novel multimodal 
system for imaging the microenvironment of bioactive scaffolds for tissue engineering 
applications in vivo. Our system facilitates the use of IOS, FL, and LSC imaging during a single 
experimental session in order to provide extensive data on the regrowth of the vascular network 
and characterization of the vascular phenotypes involved in bone healing. IOS imaging allows us 
to assess changes in vascular morphology, while FL imaging enables tracking of cell distribution 
within the scaffolds as well as measurement of tracer kinetic phenomena. LSC imaging provides 
crucial information on relative blood flow and vessel maturity within a vascular bed that is being 
dynamically remodeled during osteogenesis. Finally, the multimodal imaging in conjunction 
with the analyses methods described here make it possible to compare angiogenesis within defect 
sites across different experimental paradigms. We believe that such tools provide critical 
information to help optimize the design, implementation and deployment of future tissue 
engineering approaches for critical sized calvarial defects. 
 Future experiments should therefore seek to improve upon the healing capabilities of 
tissue engineering scaffolds by studying the types and compositions of osteogenic and 
biochemical factors that best facilitate bone and vascular remodeling. In order to further study 
the characteristics associated with improved regeneration using our imaging system and 
processing techniques, more animals should also be imaged. In this way, we may achieve a better 
understanding of important vessel characteristics through a k-means clustering analysis with a 
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